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Background. Legionella pneumophila is a waterborne cause 
of both healthcare-associated and community-acquired pneu-
monia. Legionella pneumophila serogroup 1 is responsible for 
80% of infections. There is currently limited published disease 
burden data on Legionnaires’ disease-associated hospitalization 
in the United States.
Methods. In this study, we estimated the annual incidence 
of Legionnaires’ disease-associated hospitalizations in United 
States and identified demographic, temporal, and regional 
characteristics of individuals hospitalized for Legionnaires’ dis-
ease. A retrospective study was conducted using the National 
Hospital Discharge Survey (NHDS) data from 2006 to 2010. The 
NHDS is a nationally representative US survey, which includes 
estimates of inpatient stays in short-stay hospitals in the United 
States, excluding federal, military, and Veterans Administration 
hospitals. All discharges assigned with the Legionnaires’ disease 
International Classification of Diseases 9th Clinical Modification 
discharge diagnostic code (482.84) were included in this study.
Results. We observed the annual incidence and number of 
Legionnaires’ disease-associated hospitalizations (per 100 000 
population) in the United States by year, age, sex, race, and 
region. Over a 5-year period, 14 574 individuals experienced 
Legionnaires’ disease-associated hospitalizations in the United 
States The annual population-adjusted incidence (per 100 000 
population) of Legionnaires’ disease-associated hospitaliza-
tions was 5.37 (95% confidence interval [CI], 5.12–5.64) in 
2006, 7.06 (95% CI, 6.80–7.40) in 2007, 8.77 (95% CI, 8.44–
9.11) in 2008, 17.07 (95% CI, 16.62–17.54) in 2009, and 9.66 
(95% CI, 9.32–10.01) in 2010. A summer peak of Legionnaires’ 
disease-associated hospitalizations occurred from June through 
September in 2006, 2007, 2008, and 2010.
Conclusions. Legionnaires’ disease-associated hospitaliza-
tions significantly increased over the 5-year study period. The 
increasing disease burden of Legionnaires’ disease suggests that 
large segments of the US population are at risk for exposure to 
this waterborne pathogen.
Keywords.  bacteria; hospitalizations; Legionnaires; pneu-
monia; United States.
Legionnaires’ disease (LD) is caused by the Gram-negative bac-
teria Legionella, which is responsible for a severe pneumonia 
called Legionnaires’ disease and a flu-like syndrome called Pontiac 
fever [1]. Legionnaires’ disease is one of the most common causes 
of atypical pneumonia [1]. The most common causative agent of 
LD is serogroup 1 of Legionella pneumophila [1].
In the environment, L pneumophila thrives in condi-
tions with increased temperatures, humidity, and rainfall [2]. 
Increased growth of Legionella can be found in aging water in-
frastructure where sludge, eroded pipes, and air conditioning 
vents are present [2–4]. Detection of L pneumophila has been 
reported in larger buildings, especially those found in urban 
areas of the Northeast, Midwest, and Southern United States [2, 
5]. Under appropriate conditions, acquisition of L pneumophila 
may occur via inhalation of contaminated aerosolized water [1]. 
Individuals who are older than 50  years of age, immunosup-
pressed, experience comorbid conditions, or those with history 
of smoking are at an increased risk for LD [1].
Common clinical features of LD include shortness of breath, 
fever, gastrointestinal distress, and arthralgia [1]. The most 
commonly used laboratory assay to diagnose LD is the urinary 
antigen test, which detects L pneumophila serogroup 1 antigen 
in urine within 1 to 3  days after infection and yields results 
within 15 minutes [6]. Approximately 40% of LD cases require 
intensive care unit admissions, and an estimated 5% to 10% of 
LD patients will die, in part, due to delayed or inappropriate 
treatment that highlights its potential severity [3, 7]. Trends in 
reported LD cases observed in US Centers for Disease Control 
and Prevention National Notifiable Disease Surveillance System 
data suggest that LD is gaining new prominence as a health 
threat among adults [8]. To further ascertain the burden and 
patterns of LD in the United States, we conducted an analysis 
of national hospital discharge data for the period 2006–2010.
METHODS
Data Source
We analyzed US National Hospital Discharge Survey (NHDS) 
data to estimate the annual incidence of LD-associated 
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hospitalizations from 2006 through 2010. The US NHDS cap-
tures demographic characteristics from sample of discharge 
records from short-stay, nonfederal, general, and children’s 
hospitals [9]. In the NHDS, International Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9-CM) di-
agnostic codes are used to classify patients’ medical diagnoses. 
Hospital discharge records containing the ICD-9-CM code 
for LD (482.84) were selected. Using these data, we examined 
changes in LD-associated hospitalizations by age, sex, region, 
month of discharge, and time to identify potential high-risk 
population groups that may be at increased risk for severe LD. 
The NHDS uses the US Bureau of the Census classification to 
categorize the hospitals by location into 1 of 4 US geographic 
regions (Northeast, Midwest, South, and West). The NHDS es-
timates are adjusted by using population weighting ratio, infla-
tion by reciprocals of probabilities of selection, and accounting 
for nonresponses [9].
Data Analysis
For the years 2006 through 2010, the incidence of LD-associated 
hospitalizations was calculated using SPSS software, version 25 
([IBM Corp. Released 2017] IBM SPSS Statistics for Windows, 
version 25.0; IBM Corp., Armonk, NY). United States census 
data were used to obtain national population estimates for each 
year studied. The monthly distribution of LD-associated hospi-
talizations was calculated using the month of discharge data el-
ement. Rates of LD-associated hospitalizations were calculated 
as the number of hospital discharges with the diagnostic code 
for LD listed (ICD-9-CM, 482.84) divided by the sum of the an-
nual population census estimates for each demographic group 
(eg, males, females, specified age groups, race). Incidence rates 
were calculated for the following age groups: ≤39, 40–49, 50–59, 
60–69, 70–79, and ≥ 80 years of age. Rates were reported as the 
number of LD-associated hospitalizations per 100 000 popula-
tion with 95% confidence intervals (CIs) [10].
RESULTS
A total of 14 574 LD-associated hospitalizations were identi-
fied between 2006 and 2010. The population-adjusted annual 
incidence of LD-associated hospitalizations was 5.37 (95% 
CI, 5.12–5.64) in 2006, 7.06 (95% CI, 6.80–7.40) in 2007, 8.77 
(95% CI, 8.44–9.11) in 2008, 17.07 (95% CI, 16.62–17.54) in 
2009, and 9.66 (95% CI, 9.32–10.01) in 2010 (Table 1, Figure 1). 
Individuals aged 39  years or younger had the lowest rate of 
LD-associated hospitalizations in all 5 years of the study. The 
incidence rate increased with age and peaked in the group 
60—69 years of age. With the exception of 2007 and 2009, males 
showed a significantly higher incidence rate compared with fe-
males. Among racial groups, whites had a comparatively higher 
incidence rate in 2006 and 2008, whereas rates for blacks were 
higher in 2007 and 2010. A peak in the monthly weighted hospi-
talizations is seen for the months of May–September in 4 (2006, 
2007, 2008, and 2010) of the 5 study years (Table 2, Figure 2). 
The LD-associated hospitalization incidence was higher in 
the Northeast (2 years, 2007 and 2009), Midwest (2007, 2008, 
2010), and West (2008, 2009, 2010) compared with incidence 
rates in the South in all years studied (Table 3). In 2009, notable 
spikes in the incidence of LD-associated hospitalization were 
observed in the Northeast and West regions.
DISCUSSION
The NHDS data show a sustained increase in LD-associated 
hospitalizations in the United States during 2006–2010 with 
the mean age of patients ranging from 50 to 80  years, both 
of which are reflected in data nationwide [8, 11, 12]. In our 
study, the population-adjusted incidence of LD-associated 
hospitalizations almost doubled between 2006 and 2010 (5.37 
to 9.66/100 000 population). The national incidence was 
highest during 2009 (17.07/100 000 population) and was no-
tably highest in the Northeast (30.59; 95% CI, 29.18–32.06) 
and West regions (37.30; 95% CI, 36.01–38.71). This 2009 
peak is consistent with other studies and national reports that 
document a steep increase in the number of LD cases in the 
Northeast [2, 13–15]. Although the underlying reasons for the 
increase in LD-associated hospitalizations during 2009 re-
mains unclear, several factors may be responsible, including 
an increase in cases reported from New York City, a higher 
prevalence of LD risk factors among low-income populations, 
Table 1. Incidence of LD-Associated Hospitalizations (per 100 000 Population) With 95% CI From National Hospital Discharge Survey, United States, 
2006–2010 by Age Group
Year
Age Group, Years  
IR (95% CI)
Total ≤39 40 to 49 50 to 59 60 to 69 70 to 79 ≥80
2006 5.37 (5.12–5.64) 0.07 (0.04–0.12) 3.70 (3.18–4.30) 12.12 (11.08–13.26) 14.70 (13.30–16.31) 23.80 (21.60–26.30) 20.71 (18.21–23.60)
2007 7.06 (6.80–7.40) 0.22 (0.16–0.30) 4.72 (4.12–5.4) 22.15 (20.74–23.70) 9.55 (8.42–10.83) 8.92 (7.60–10.50) 55.57 (51.48–60.01)
2008 8.77 (8.44–9.11) 1.83 (1.63–2.04) 3.30 (2.81–4.01) 6.42 (5.70–7.24) 59.85 (57.10–62.80) 20.87 (18.80–23.2) 2.96 (2.12–4.14)
2009 17.07 (16.62–17.54) 5.60 (5.30–6.01) 32.47 (31.01–34.20) 7.61 (7.01–8.51) 89.58 (86.30–93.01) 5.51 (4.50–6.80) 0
2010 9.66 (9.32–10.01) 2.18 (1.97–2.41) 15.57 (14.44–16.78) 21.03 (19.68–22.46) 6.90 (6.00–7.92) 28.50 (26.07–31.14) 34.09 (30.96–37.53)
Abbreviations: CI, confidence interval; IR, incidence rate; LD, Legionnaires’ disease.
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Figure 1. Weighted total number and annual incidence of Legionnaires’ disease-associated hospitalizations, 2006–2010.
Table 2. Incidence of LD-Associated Hospitalizations (per 100 000 Population) With 95% CI From National Hospital Discharge Survey, United States, 






Female Male White Black Others Not Stated
2006 3.64 (3.35–4.0) 7.17 (6.74–7.61) 4.08 (3.83–4.34) 3.02 (2.51–3.62) 1.18 (0.80–1.75) ---
2007 8.41 (8.01–9.01) 5.67 (5.30–6.10) 3.82 (3.60–4.10) 7.11 (6.31–8.01) --- ---
2008 2.59 (2.40–2.90) 15.15 (14.60–15.80) 4.64 (4.41–5.01) --- --- ---
2009 21.24 (20.53–22.01) 12.77 (12.21–13.35) 6.25 (6.01–6.60) 4.39 (3.80–5.10) 54.98 (52.11–58.01) ---
2010 6.79 (6.40–7.21) 12.61 (12.06–13.19) 5.40 (5.11–5.69) 17.62 (16.38–18.96) --- ---
























































































Figure 2. Monthly distribution of weighted Legionnaires’ disease-associated hospitalizations over 5 consecutive years, 2006–2010.
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and maintenance of water systems particularly those found in 
large buildings [13, 15].
This study has some limitations. First, the NHDS database 
provides inpatient hospitalization data and does not reflect 
individuals who may have received care for LD in military, 
Veterans Administration hospitals, or in emergency de-
partments only. Second, racial group information was not 
reported in 42.2% of hospitalizations analyzed. This obser-
vation may lead to unreliable estimates of the LD-associated 
hospitalization burden in race-specific groups. Third, sea-
sonality studies have shown that LD patterns typically 
demonstrate a summer spike, with an increased incidence 
occurring during the warmer, more humid months of June–
September [4]. With NHDS data, however, we cannot as-
certain the precise time and location of the acquisition of 
infection. Nevertheless, because the date of illness onset and 
data of admission are likely to be within 4 weeks of each 
other, the epidemiologic onset curve is likely to appear sim-
ilar to the graph of hospitalizations described in this report.
CONCLUSIONS
Legionnaires’ disease is an important cause of hospitalization 
among Americans. Surveillance and research investigations 
suggest that LD cases have substantial potential to increase in 
coming years due to aging of the US population, aging infra-
structure, and changing climatic factors [2]. This underscores 
the importance of the understanding of this disease’s character-
istics and early diagnosis of Legionella pneumophila infection 
among patients to prevent severe clinical sequelae. Improved 
knowledge and access to Legionella diagnostic assays may also 
help to improve the timeliness of treatment and reduce health-
care costs associated with LD.
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Table 3. Incidence of LD-Associated Hospitalizations (per 100 000 
Population) With 95% CI From National Hospital Discharge Survey, United 




Northeast South West Midwest
2006 2.96 (2.54–3.50) 5.99 (5.54–
6.50)
4.59 (4.11–5.12) 7.17 (6.60–
7.84)





2008 4.48 (4.01–5.10) 3.57 (3.23–
4.01)
13.64 (13.01–14.60) 15.83 
(15.01–17.01)
2009 30.59 (29.18–32.06) 3.04 (2.73–
3.40)
37.30 (36.01–38.71) 7.99 (7.34–
8.70)
2010 5.55 (4.96–6.20) 9.49 (8.94–
10.07)
10.85 (10.12–11.63) 12.09 
(11.29–
12.94)
Abbreviations: CI, confidence interval; IR, incidence rate; LD, Legionnaires’ disease.
aList of States by region. Northeast: Maine, New Hampshire, Vermont, Massachusetts, 
Connecticut, Rhode Island, New York, New Jersey, Pennsylvania. Midwest: Michigan, 
Ohio, Illinois, Indiana, Wisconsin, Minnesota, Iowa, Missouri, North Dakota, South Dakota, 
Nebraska, Kansas. South: Delaware, Maryland, District of Columbia, Virginia, West 
Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Alabama, 
Mississippi, Arkansas, Louisiana, Oklahoma, Texas. West: Montana, Idaho, Wyoming, 
Colorado, New Mexico, Arizona, Utah, Nevada, Washington, Oregon, California, Hawaii, 
Alaska.
